分享 收藏

Recombinant Human HBV (HLA-A*02:01) Protein, His-Avi Tag

品牌：翌圣生物
產地：
供應商報價：面議

翌圣生物科技(上海)股份有限公司更新時間：2025-04-02 09:01:18

銷售范圍售全國

入駐年限第2年

營業執照已審核

同類產品抗體藥物靶點蛋白(1446件)

立即掃碼咨詢

聯系方式：400-611-1883

聯系我們時請說明在儀器網（m.ghhbs.com.cn）上看到的!

掃碼分享

為您推薦

Recombinant Cynomolgus IL-13 Protein,His Tag

Recombinant Cynomolgus IL-4 Protein,His Tag
Recombinant Cynomolgus IL-6 Protein,His Tag

Recombinant Cynomolgus IL-3 Protein,His Tag
Recombinant Cynomolgus IL-1 Beta/IL-1F2 Protein,His Tag

Recombinant Cynomolgus IL-1 alpha/IL-1A Protein,His Tag

詳細介紹

Hepatitis B virus (HBV), is the leading cause of liver diseases . The Human HLA-A*0201 HBV (FLLTKILTI) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and FLLTKILTI peptide of the HBV.

性能參數

Synonyms	Hepatitis B virus; MHC; HBV
Uniprot No.	A0A140T913(HLA-A*02:01)&P61769(B2M)&FLLTRILTI peptide
Source	Recombinant Human HBV(HLA-A02:01) Protein is expressed from HEK293 cells with His tag and Avi tag at the C-terminal It contains Gly25-Thr305(HLA-A02:01),Ile21-Met119(B2M) and FLLTRILTI peptide.
Molecular Weight	The protein has a predicted MW of 50.5 kDa. Due to glycosylation, the protein migrates to 52-62 kDa based on Tris-Bis PAGE result.
Purity	> 95% as determined by SDS-PAGE and HPLC.
Endotoxin	<1.0 EU per 1μg of the protein by the LAL method.
Formulation	Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution	Centrifuge tubes before opening. Dissolve lyophilized protein with sterile water to ensure the concentration is greater than 100 ug/mL.